What are the news: WADA has announced an editorial update to the Current Procedural Terminology (CPT®) code set that includes a new vaccine delivery code for a third dose of the pediatric COVID-19 vaccine developed by Pfizer.
The new CPT code went into effect in January for use when the Food and Drug Administration (FDA) extended its emergency use authorization to include a third primary series dose of Pfizer’s COVID-19 pediatric vaccine for certain children ages 5 to 11 with compromised immune systems.
The AMA commended the actions of federal agencies to expand the use of the Pfizer COVID-19 vaccine in a statement and urged full vaccination for newly eligible children and adolescents.
“Although children 5 years and older have been eligible to receive the Pfizer-BioNTech COVID-19 vaccine since November 2021, vaccination rates among children and adolescents remain low,” said WADA President Gerald E. Harmon, MD. “We strongly urge all parents to fully vaccinate their children as soon as they are eligible.”
Find out what doctors want parents to know about the safety of the COVID-19 vaccine for children.
Why it matters: Developing CPT codes that clinically distinguish each coronavirus vaccine and dosing schedule enables data-driven tracking, reporting and analysis that supports planning and allocation during the public health response to the pandemic. COVID-19 vaccines from AstraZeneca, Janssen (Johnson & Johnson), Moderna, Novavax and Pfizer have already received unique CPT codes.
To help ensure accurate coding and reporting of COVID-19 vaccines and immunization services, the AMA offers a Vaccine Code Lookup Resource to help identify the appropriate CPT code combination for the type and dose of COVID-19 vaccine provided to each patient.
For quick reference, the new vaccine administration code assigned to the third dose of Pfizer’s COVID-19 pediatric vaccine is:
0073A—Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) intramuscular injection immunization administration (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, no preservative, 10 mcg/0.2 mL dose, reconstituted diluent, tris-sucrose formulation; third dose
Short, medium, and long descriptors for all new vaccine-specific CPT codes can be accessed on the WADA website, along with other recent changes to the CPT code set that have helped streamline the healthcare response. public to the SARS-CoV-2 virus and COVID-19 disease.
Find out how the CPT codeset has evolved amid the pandemic and compensation challenges and is “not your grandma’s CPT”.
Learn more: Changes to the CPT code set are reviewed through an open editorial process managed by the CPT Editorial Board which garners extensive input from the healthcare community and beyond to ensure that CPT content reflects requirements. of coding digital health, precision medicine, augmented intelligence and other aspects of a modern healthcare system.
This rigorous editorial process keeps the CPT code set up to date with contemporary medical science and technology so that it can fulfill its vital role as the trusted language of medicine today and the code for its future.
Questions about CPT coding and content should be directed to the CPT network, the authoritative source for CPT coding answers. Also check out the AMA’s online library of COVID-19 CPT coding and guidance.